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Substrate binding and sequence preference of the proteasome 
revealed by active-site-directed affinity probes 
Matthew Bogyo, Sunny Shin, John S McMaster* and Hidde L Ploegh 
Background: The proteasome is a multicatalytic protease complex responsible 
for most cytosolic protein breakdown. The complex has several distinct 
proteolytic activities that are defined by the preference of each for the carboxy- 
terminal (Pl) amino acid residue. Although mutational studies in yeast have 
begun to define substrate specificities of individual catalytically active 
0 subunits, little is known about the principles that govern substrate hydrolysis 
by the proteasome. 
Results: A series of tripeptide and tetrapeptide vinyl sulfones were used to 
study substrate binding and specificity of the proteasome. Removal of the 
aromatic amino-terming1 cap of the potent tripeptide vinyl sulfone proteasome 
inhibitor 4-hydroxy-3-iodo-2-nitrophenyl-leucinyl-leucinyl-leucine vinyl sulfone 
resulted in the complete loss of binding and inhibition. Addition of a fourth 
amino acid (P4) to the tri-leucine core sequence fully restored inhibitory 
potency. 1251-labeled peptide vinyl sulfones were also used to examine inhibitor 
binding and to determine the correlation of subunit modification with inhibition 
of peptidase activity. Changing the amino acid in the P4 position resulted in 
dramatically different profiles of P-subunit modification. 
Conclusions: The P4 position, distal to the site of hydrolysis, is important in 
defining substrate processing by the proteasome. We observed direct 
correlations between subunit modification and inhibition of distinct proteolytic 
activities, allowing the assignment of activities to individual p subunits. The ability 
of tetrapeptides, but not tripeptide vinyl sulfones, to act as substrates for the 
proteasome suggests there could be a minimal length requirement for hydrolysis 
by the proteasome. These studies indicate that it is possible to generate 
inhibitors that are largely specific for individual p subunits of the proteasome by 
modulation of the P4 and carboxy-terminal vinyl sulfone moieties. 
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Introduction 
The proteasomc is a large, barrel-shaped multisubunit 
proteasc involved in most cytosolic proteolpsis. It is 
made up of four stacked rings, each composed of seven 
a- or b-type subunits. Some of the p subunits are catalyt- 
ically active: the cx subunits appear to have mainly a 
structural role [l]. The eukaryotic proteasome contains 
three active p subunits repeated twice in the complex, 
whereas archaebacteria and eubacteria have only a single 
catal>-tic p subunit. The proteasome can degrade a wide 
variety of substrates that differ in the amino acid 
sidechain found at the site of hydrolysis [2]. The multi- 
ple peptidasc activities have different preferences for the 
sidechain at the site of hydrolysis, and have been named 
accordingly as the chymotrypsin-like, trypsin-like, post- 
glutamyl pcptide hydrolyzing (PGPH) and branched- 
chain amino-acid peptidase (RrAAP) activities. Although 
mutational studies in yeast have linked specific pepti- 
dase activities to individual p subunits. a direct correla- 
tion in mammalian cells is lacking. 
The proteasome employs a rather unusual catalytic mech- 
anism and is a member of the family of enzymes known 
as amino-terminal hydrolases. This class of enzyme uti- 
lizes an amino-terminal amino acid as the catalytic 
residue. The proteasome’s amino-terminal threonine 
hydroxyl sidechain is activated by a single water molecule 
involving a charge relay system with other important 
internal amino acids such as lysine [1,X]. As a threonine 
protease, the proteasome does not fall into a standard cat- 
egory with other proteolytic enzymes in terms of its reac- 
tivity towards inhibitors. The sensitivity of the threonine 
protease to serine- as well as cysteine-protease inhibitors 
complicated its initial characterization [Z]. Quite surpris- 
ing is the variety of carboxy-terminally modified peptides 
that are reactive with the proteasome’s amino-terminal 
catalytic residue [4-91. 
The ability to modulate the activity of the proteasome 
experimentally using small molecule inhibitors is central 
to understanding the mechanism of action of this enzyme 
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complex. ‘I’he natural product lactacystin irreversibly 
inhibits the proteasomc by cov-alent modification of the 
catalytic threoninc hydroxyl group [l&l 11. The lack of 
structural similarity between lactacystin and carboxy-ter- 
minally modified pcptides suggests that these two classes 
of inhibitors may bind to the protcasome’s active sites dif- 
ferently. ‘I‘his suggestion was verified with the determina- 
tion of the crystal structure of the T~mno@mna 20s 
proteasome [lZ] and, more recently, the yeast 20s protea- 
some [ 131. Cr!;stals of proteasomes obtained in a complex 
with either the peptide aldehyde (:bz-leucinyl-lcucinyt- 
norleucinal (LI,nI, or calpain I inhibitor) or lactacystin 
indicate that the two inhibitors do not interact with the 
proteasomc equil,alcntly. lrnlikc LLnL, which bound all 
three catalytically active p subunits (PUP1 or %, PRIG’ or 
X, and PRE3 or Y), lactacystin predominantly targeted the 
X p subunit [13]. ‘I‘hus, although lactacystin may be a spe- 
cific inhibitor of the proteasome it is unlikely to be of use 
in further studies of the proteasome’s substrate specificity 
for polypeptide substrates. 
Because of the proteasomc’s role in the production of anti- 
gcnic peptides and in the activation of signaling molecules 
required for inflammation, inhibitors of the proteasome 
are being explored for USC as potential anti-inflammatory 
agents and for treatment of auto-immune diseases. The 
usefulness of such inhibitors depends on their bioavail- 
ability and cell permeability, criteria that favor small 
hydrophobic, nonpeptide compounds. Although such 
compounds are potentially useful as therapeutic agents, 
they are unlikely to mimic a protein substrate accurately 
and therefore fail to provide information about catalytic 
mechanism and substrate specificity. 
The yeast ZOS proteasome crystal structure suggested the 
possibility of other active sites within the large multi- 
subunit complex that do not employ a catalytic amino-ter- 
minal threonine residue [13]. hlultiple magnesium-binding 
sites create an acidic environment within the center of the 
proteasome’s internal cavity. Thus, bound water molecules 
might serve as catalytic nucleophiles, in the same way as 
they do in hydrolysis by aspartyl proteases. Short peptide- 
based inhibitors and fluorogenic substrates might not 
access such a secondary binding pocket, and therefore 
might not accurately mimic substrate binding. It is there- 
fore possible that additional protcasome-substrate interac- 
tions could be studied by using longer peptides. 
\\:c describe here the synthesis and characterization of a 
series of peptidc vinyl sulfoncs of different amino acid 
sequences, lengths, and carboxy- and amino-terminal mod- 
ification. ‘I‘hese inhibitors are all equipped with a carboxy- 
terminal vinyl sulfone that covalently modifies the catalytic 
amino-terminal threonine residue of the proteasome [4]. 
Tripcptide vinyl sulfones containing a free amino terminus 
do not inhibit protcasomal proteolysis, but the addition of a 
Figure 1 
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The P-notation used to identify sequence positions on a substrate or 
inhibitor relative to the site of amide-bond hydrolysis. 
fourth amino acid (at position P4; Figure 1) results in a dra- 
matic increase in inhibitor potency. When the inhibitors 
are labeled with lzsI, binding to proteasomal subunits can 
be assessed directly using electrophoretic methods. 7’he 
amino acid sidechain in the P4 position of the inhibitor 
defines which subunits are modified by the inhibitor, and 
therefore which activities are blocked to the greatest 
extent. The P4 region of a substrate is a likely recognition 
element that helps to define the sequence of peptides pro- 
duced by the proteasome. Labeling profiles obtained for 
different inhibitors also allow a correlation of inhibition of 
substrate hydrolysis with the subunit(s) modified. 
Results 
Synthesis of peptide vinyl sulfones 
A series of tripeptide and tetrapeptide methyl vinyl sul- 
fonts were synthesized based on the core sequence 
Leu-Leu-Leu (LLL), previously described as a potent 
inhibitor of the proteasome [4] (Figure 2). The peptide 
briny] sulfones inhibit the proteasome by specific, covalent 
modification of the amino-terminal threonine on the cat- 
alytically active p subunits [4]. This class of compounds 
has no reactivity against circulating free nucleophiles such 
as the thiol group of glutathione [14]. We also synthesized 
a related derivative in which the methyl group adjacent to 
the sulfonc moiety was replaced with a phenolic group 
(these vinyl sulfones will be referred to as phenolic vinyl 
sulfones (VS-PhOH), whereas the methyl vinyl sulfones 
will be simply called vinyl sulfones (VS); Figure 2). The 
phenolic substituent allows attachment of lZjI at the 
carboxy-terminal end of the peptide vinyl sulfones. 
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Figure 2 
(a) Methyl vinyl sulfones 
NLVS 
NP-AAF-VS 
NP-LLG-VS 
OH 
, (b) Phenolic vinyl sulfones 
NLVS-PhOH 
GL&S-PhOH 
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Structures of several peptide vinyl sulfones containing (a) a methyl 
group or (b) a phenolic group adjacent to the vinyl sulfone moiety. 
NLVS, 4-hydroxy-3-iodo-2-nitrophenyl-leucinyl-leucinyl-leucine vinyl 
sulfone; NP, 4-hydroxy-3-nitrophenyl acetyl; PhOH, phenolic group; all 
other letters correspond to single-letter amino-acid code. 
The L, tripeptide vinyl sulfone with a free amino termi- 
nus (Figure 3) was extended by addition of an amino acid 
at the P4 position. To examine the effects of the P4 
amino acid on covalent modification we synthesized the 
sequences GLLL (GI,3-\TS). ‘I’IJIJI, (YI,;-\TS), YAAF 
(YAAF-13) and LLLL (L,-\.S) as the corresponding 
peptide Cnyl sulfones (single-letter amino-acid code is 
used to define the amino acids in the peptides). ‘1‘0 
examine whether the binding of the P-l amino acid W;IS 
sensitive to chiral geometr)-, the I)-isomer of tvrosine was 
also added at 1’1 ((I))YI,,~-\‘S). \Ve also introduced the 
non-natural amino acid henzo~l-phen)lal~lninc (13pa) in 
the P4 position (Rpa-I,,- VS) to cxaminc 11 hcthcr thi5 
bulky sidechain could be accommodated b>- a sccondar! 
binding site (Figure 3). 
‘The scqucncc I,LG was synthesized to examine the 
importance of the Pl position and AAF was synthcsizcd to 
determine the effects of a more substantial scqucncc 
change on binding. ‘I’he lack of a sidechain at the 1’1 posi- 
tion in the LLG peptide resulted in the gcncration of a 
mixture of I-is and t/at~.s gcomctric isomers of the vinyl 
sulfone group that could bc separated by chrotnatogrllph! 
and used to cxaminc rtcric cffccts at the site of hytlrol\-sis 
in the acti\;e site. 
P4 amino acid influences inhibition of fluorogenic 
substrate hydrolysis 
Hydrolysis of the proteasome substrates Sue-l,l,L3‘- 
A\I(Z (a substrate for the ch\-motrypsin-like acti\ ity; 
AIZIC. 7-amid0 I-mcthylcollmarin), Rot-I,lili-Xhl(: (a 
substrate for the trypsin-like actis,ity) and AC-\r’\‘.Al)- 
AhlC (a substrate for the PGI’H acti\,ity) was measured. 
Ac-Y\‘AD w-as chosen as a substrate rather than the clas- 
sical P(iP1-I substrate Rot-LLK-BNA. because it more 
closely matches the structure of the tetrapeptidc 
inhibitors used in this study. Although it is difficult to 
determine whether both substrates arc hydrolyzed by the 
same active sites, Ac-\r’\‘,L\D-.AhlC pro\idcs information 
about a protcasomal acti\Aty that is biochemically distinct 
from the chymotrypsin- and tr?psin-like acti\ ities. As 
pre\-iously reported [A], the compound 4-tiJ.dros)--.i-iodo- 
Z-nitrophenyl-leucinyl-leucinyl-lcucinc \ inyl sulfone 
(NLVS) inhibited multiple proteasome acti\ itics \z ith 
the fastest rate of inactivation of the ch~motr)-psin-like 
activity followed by the PGPH and trvpsin-like acti\ i- 
ties. The omission of the amino-terminal carboxylbcnzyl 
or nitro-iodo phenol yielded a free-amino compound that 
was only weaklv inhibitor\- against all three substrates 
(Table 1). ‘The. free amin;, tetrapeptidc \ in)-1 sulfoncs 
Yl,,3-C:S. BpaI,,,-VS and I,,-\.S, on the other hand. dis- 
played inhibition kinetics similar to or better than those 
obscrvcd for the amino-capped tripeptide NI,\-S 
(Figure 4; Table 1). Of the three activities cxamincd. inhi- 
bition of the trypsin-like activity ~YIS most dramatically- 
increased I~\ the addition of an aromatic, aliphatic. or 
bulky P4 amino acid. Further, the inhibition rate constants 
for the chymotrypsin-like and tr) psin-like substrates dif- 
fered, depending on the P4 amino acid. I,,-\.S showcd a 
sixfold reduction in activity against the ch~motr~l,sin-lil~e 
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Figure 3 
BpaL,-VS , 
GL,-VS 
GL,-VS-PhOH 
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Structures of the free amino tripeptide and 
tetrapeptide vinyl sulfones. Amino acids are 
designated using the single-letter amino-acid 
code. Bpa, benzoyl-phenylalanine. 
activity and a threefold increase in activity against the 
trypsin-like activity when compared to YL,3-VS. 
The related compound in which the P4 tyrosine was 
replaced with the II-isomer ((n)YL,-VS) was less active 
than its diastereomeric equivalent (YL,-VS), but showed 
increased reactivity compared to I,,3-yS (‘l’able 1). The 
inhibitory capacity of YL,3-\‘S against all three activities 
was reduced by replacement of the I,-isomer for the I)- 
isomer at Pl. The trypsin-like activity was most affected 
(97% reduction) followed by the chymotrypsin-like activ- 
ity (9.5% reduction), and finally the PGPH activity (75% 
reduction). Although the binding interaction of the P4 
amino acid is sensitive to chiral geometry it does not 
exclude binding of a u-isomer at this position, as shown 
previously to be the case for the Pl position [4]. 
The tetrapeptide GL,-VS, unlike the other teuapeptides 
studied, has no sidechain at the P4 position. This com- 
pound showed dramatically reduced activity against hydrol- 
ysis of all three substrates when compared to YL,-VS. 
PI~~-L,~-VS and I,,-VS (‘l’able 1). The rate constant for 
(;I,,-\?3 inhibition of the PGPH activity most closely 
matched the rates observed for YL,-VS, Rpa-L,3-VS, and 
L,-VS (the GL,3-\‘S:YL,,3-VS ratio was 1 l%, compared to 
1.5% and 2% for the chymotrypsin- and trypsin-like 
activities respectively). Furthermore, upon prolonged 
incubation of proteasomes uith GI,,3-\‘S, appreciable 
inhibition \vas observed for only the PGPH activity (data 
not shown). ‘I’hese data indicate that the active sites for 
all three proteolytic activities prefer a hydrophobic or 
aliphatic P4 amino acid, but the requirements for this 
binding site may be different for different acti\,e sites. 
A similar increase in inhibitory activity was observed 
when tyrosinc was placed in the P4 position by addition 
to the tripeptide AAF-VS, indicating that P4 binding is 
not dependent on the sequences at Pl-3, but rather is a 
more general phenomenon that leads to increased 
potency of inhibitors (data not shown). Again, the great- 
est enhancement of activity was observed against the 
trypsin-like activity. 
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Table 1 
Kinetic constants for the peptide vinyl sulfones and lactacystin against hydrolysis of three proteasomal substrates. 
k,,,/[ll 
Inhibitor Sue-LLVY-AMC Boc-LRR-AMC AC-YVAD-AMC 
Lactacystin 
NLVS-PhOH 
NLVS 
L,-vs 
Y L,-vs 
(D)YL,-vs 
BpaL,-VS 
L,-vs 
GL,-VS 
GL,-VS-PhOH 
NP-AAF-VS 
NP-LLG-VS 
1,500 (0.2-0.5 PM) 110(5-10pM) 17 (25-l 00 PM) 
13,400 (0.1-0.5 PM) 422 (25-50 /.tM) 100 (1 O-25 PM) 
13,500 (0.1-0.5 PM) 10 (50-l 00) PM) 24 (50-l 00 PM) 
2.7 (100-500 FM) 11 (50-250 PM) 0.21 (100-500 PM) 
1,500 (2-6 PM) 560 (2-l 0 PM) 77 (825 PM) 
77 (5-25 FM) 20 (50-l 00 FM) 20 (50-l 00 ,uM) 
960 (0.8-3.2 PM) 2,370 (0.5-l FM) 63 (1 O-20 yM) 
240 (5-l 5 PM) 1,500 (0.5-2.5 FM) 29 (1550 PM) 
21 (25-l 00 PM) 12 (25-l 00 PM) 8.0 (75-250 PM) 
57 (50-l 00 JIM) 14 (50-l 00 PM) 23 (50-l 00 PM) 
68 (2-l 5 PM) 14 (75-l 00 PM) ND 
28 (25-50 PM) ND ND 
Hydrolysis of Sue-LLVY-AMC (chymotrypsin-like activity), Boc-LRR- 
AMC (trypsin-like activity), and AC-YVAD-AMC (PGPH activity) was 
monitored after the addition of inhibitors listed above in the given 
concentration ranges (values In parentheses). Inhibition curves were 
plotted and fit to the equation for a slow binding covalent inhibitor as 
described In the Materials and methods section. Results are presented 
Inhibition profiles for the chymotrypsin-like, trypsin-like 
and PGPH substrates obtained upon treatment of intact 
cells with several of the tripeptide and tetrapeptide vinyl 
sulfones agreed with the kinetic data described for 
sodium dodecyl sulfate (SDS)-activated 20s proteasomes 
(data not shown). Furthermore, kinetic rate constants 
obtained for NL\-S using purified 26s proteasomes were 
similar to those obtained using SDS-activated 2% pro- 
tcasomes (data not shown). These data suggest that 
although the presence of additional regulatory subunits 
may result in subtle changes to the pattern of inhibition 
by various peptide vinyl sulfones. the kinetic data 
obtained for SDS-activated ZOS protcasomes is likely to 
bc representative of the multiple physiologically rele\.ant 
proteasomc complexes that exist within a cell. 
Labeling of proteasomes with tetrapeptide vinyl sulfones 
‘I’hc labeling pattern of proteasomes with the tripeptide 
“‘I-NL\% has been described [4]. This compound cova- 
Icntly labels multiple p subunits including the interferon-y 
(1 l;N-y) inducible I,hIP-2 and LhlP-7 subunits. 
SDS-polyacrylamide gel electrophoresis (PAGE) analysis 
of ‘ZiI-NL,\~S-labeled proteasomes rer.ealed covalent 
modification of three subunits that overlap because of 
their nearly identical molecular weights, but which are 
easily rcsolked using two-dimensional isoelectric focusing 
(IEF-SDS-P.1GE. 
.I’o further identify the subunits modified by the peptide 
Cnyl sulfones, total cell lysates were labeled with the 
as a average of k,,,/[l] values obtained for three different inhlbitor 
concentrations. The kinetic rate constants for inhibition for several 
inhibitors could not be determined due to solubility problems and 
absorption of the nitro phenol group at high concentrations. These 
samples are llsted as ND and are assumed to be quite small relative to 
the reported values for the other inhibitors. 
tetrapeptide vinyl sulfone ‘z51-YL,3-VS. 20s and 26s 
proteasome complexes were immunoprecipitated with an 
antiserum that recognized the intact proteasome 
complex, denatured, and re-immunoprecipitated with 
P-subunit-specific antisera. All six catalytically active 
p subunits were modified by ““I-YL,-VS and the identity 
of each can now be confirmed on the basis of molecular 
weight and isoelectric point (Figure 5). 
““1-NLVS labeled a band of approximately 23 kDa with 
greatest intensity in total lysates. In human cells, this pre- 
dominant labeled band was shown to be made up of three 
polypeptides upon two-dimensional gel analysis [4]. In 
mouse cells. the major 23 kDa species is accompanied by a 
second slightly smaller polypeptide of -22 kDa. Results 
from the re-immunoprecipitation experiment confirmed 
the identity of the 22 kDa polypeptide as LMP-2 and the 
23 kDa polypeptides as LMP-7, X and Y. ‘I’wo much less 
intensely labeled polypeptides were observed at around 
28 and 30 kDa and can now be identified as subunits 
r\Iecl-1 and Z respectively. Interestingly, in samples 
labeled with 1zsI-YL,3-\‘S the Z subunit was modified to a 
much greater extent than observed for ‘““I-KLVS 
(Figure 6). ‘I’hus, the addition of a bulky aromatic P4 
amino acid resulted in increased binding specifically to 
the \lecl-1 and Z subunits. 
The P4 position is important for P-subunit modification 
Based on the finding that GI,,-\‘S is a poor inhibitor of 
the trypsin-like and chymotrypsin-like activities of the 
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Figure 4 
Tz :a) 
( :b) 
80- 
60- 
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Kinetics of inhibition of fluorogenic substrate hydrolysis by the free amino 
tetrapeptide vinyl sulfones as compared to lactacystin, NLVS and free 
amino tripeptide vinyl sulfone L,-VS. k,,,,,, (k,,,/[l]) values are plotted for 
the indicated inhibitors against the three proteasomal fluorogenic 
substrates (a) Sue-LLVY-AMC (chymotrypsin-like activity), (b) Boc-LRR- 
AMC (trypsin-like activity), and (c) AC-YVAD-AMC (PGPH activity). 
proteasome but a fairly good inhibitor of the PGPH activ- 
ity, we next examined whether this difference in activity 
could be correlated with subunit modification. Partially 
purified preparations of proteasomes \vcre labeled with 
i2il-Yl -VS in the simultaneous prcsencc of increasing ‘3 L 
concentrations of Nl,VS, YlJ3-13, Gl,,3-\‘S, HpaL,3-VS and 
I,,-\?+ (Figure 7). ‘l’he competition experiment indicated 
that Yl,3-\3 was able to compctc for binding to all 
polypeptides labeled with ‘2”l-YI,,3-VS. whereas GlJ3-VS 
only blocked binding of ‘2il-Yl.,3-\% to LIZIP-2. This result, 
combined with the data obtained for substratc hydrolysis, 
pro\,ides a direct correlation between the l,blP-2 subunit 
and the PGPII activity of the mammalian protcasome. 
Placement of the bulky non-natural amino acid ben- 
zo)Iphcnylakminc at the P4 position resulted in an 
inhibitor with an activit) profile similar to that of YlJ,3-VS. 
RpaL3-VS competes for binding with ““I-YL,-VS to the 
Z and Mecl-1 subunits with greatest affinity, followed by 
the LhlP-Z subunit and finally the LhlP-7 and X sub- 
units. Conversely, N1,l.S favors modification of the 
LhlP-7 and X subunits, with only weak reactivity against 
the Z and hlecl-1 subunits. Placement of a leucine 
residue at the I’4 position again increases the potency 
towards the % and hlccl-1 subunits while reducing 
potency towards X and LhlP-7. ‘l-he amino acid composi- 
tion at position P4 can thus help define the binding of a 
substrate to a particular active site. 
Modifications at the carboxyl terminus of the peptide vinyl 
sulfones 
l’he activities of peptide vinyl sulfoncs containing a 
phenol moiety adjacent to the sulfonc group were com- 
pared to those of peptide vinyl sulfones containing a 
methyl group. ‘I’hesc compounds allow the examination of 
binding interactions at the carboxy-terminal side of a pre- 
dicted site of hydrolysis (likely to mimic the Pl’ position). 
Interestingly, replacement of the methyl group in the 
compound NLVS with the phenol (Nl,C’S-PhOH) 
resulted in no change in the potency of the compound 
against hydrolysis of l,I,VY, but resulted in a M-fold 
increase in potenq against the 1,RR substrate and a four- 
fold increase against the Y\‘AD substrate (‘l’able 1). Dif- 
fcrcnt active sites in the proteasome arc therefore likely to 
have distinct specificities for the region carboxy-terminal 
to the site of hydrolysis. 
The iodinated forms of the phenolic peptide vinyl sul- 
fones were used to examine the effects of structural varia- 
tion of the carboxy-terminal vinyl sulfone on subunit 
modification. PartialI)- purified proteasome preparations 
were labeled with the methyl-vinyl-sulfone-containing 
Nl,VS, as well as with NLVS-PhOH (Figure 8). The 
labeling patterns obtained for these inhibitors were dis- 
tinct, with the greatest difference in intensity of labeling 
observed for the LXIP-2 subunit. 
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Figure 5 
Identification of catalytically active p subunits 
modified by i251-YL,-VS by re-immuno- 
precipitation (2” IP) using subunit-specific 
antisera. lo IP, anti-mouse proteasome. 
A 
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Synthesis of the tripeptide NP-1,1X-VS resulted in the were equipped with an lzsI moiety. ‘l’hc IUJM.S isomer. 
isolation of the o.s and tuuz.s isomers of the carboxy-tcrmi- although a weaker inhibitor than the I,I,I, cqui\~alcnt. 
nal vinyl sulfone. Interestingly, the ability of the isomers was still able to covalcntly tag proteusomal B subunits. 
to inhibit substrate hydrolysis was quite different: the (is ‘I’hc c.is isomer. on the other hand, failed to label an): 
isomer had little or no inhibitory capacity against any of polypcptidcs in the size range (ZO-i0 kI1a) expected for 
the substrates, whereas the ~rzns isomer was merely less the protcasomc, but efficiently labeled several other 
active when compared to tripeptides containing three spccics of higher molecular weight (data not shown). 
leucine residues (data not shown). Even more surprising The identity of thcsc additional polypeptides \SX not 
QXS the labeling pattern observed when these isomers established. Thus, unlike rcplaccmcnt of a methyl with ;I 
Figure 6 
Addition of a bulky, aromatic sidechain in the 
P4 position increases modification of the 
Mecl-1 and Z subunits of the proteasome. 
(a) Total lysates from EL-4 cells were labeled 
with 1251-NLVS and 1251-YL,-VS and separated 
by one-dimensional SDS-PAGE either directly 
(left panel) or immunoprecipitated with a 
proteasome specific antiserum and then 
separated by SDS-PAGE (right panel). 
(b) lmmunoprecipitates from (a) were also 
separated by two-dimensional SDS-PAGE. 
The doubling of spots in the 1251-YL,-VS 
samples (bottom panel) was due to the 
lodination of either o&o- or mefa- to the 
phenolic hydroxyl group on tyrosine resulting in 
a minor change in the pK, of this proton and 
therefore a slightly different isoelectric point of 
proteins modified by this inhibitor. 
(a) 
Direct load IP a Droteasome 
(b) 
NLVS ‘+YL,-VS ljlLVS ‘*~I-YLo 
130- 
90- 
70- 
60- 
-Z 
~ Mecl-l 
~ X, LMP-7, Y 
- LMP-2 
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Figure 7 
(a) 
‘*vYL,-vs 
Competitor: 
(W 
0 1 5 10 50 FM 
-z- 
Mecl-1 - 
X,Y, LMP-7- O-I 
-LMP-2 + 100~-----’ 1 ‘-->A 1 
NLVS 
BpaL,-VS 
BpaL,-VS 
GL,-VS 
0 25 50 
Concentration (wM) 
Chemlstrv & B~oloov 
Changes in the P4 amino acid of the 
tetrapeptide vinyl sulfones results in changes 
in the pattern of p subunits modified. (a) NLVS 
and the tetrapeptide vinyl sulfones were added 
simultaneously with “%YL,-VS to EL-4 lysates 
and labeled polypeptides separated by 
SDS-PAGE as described in the Materials and 
methods section. (b) Densltometry profiles of 
the percent competition (y axis) versus 
Inhibitor concentration (x axis) based on the 
data from (a). 
phenol moiety, which resulted in only minor change in 
activity, the sharp kink induced in the carboxyl terminus 
by the cis double bond effectively precludes binding. 
Inhibitor binding to /3 subunits is sequence specific 
7‘0 investigate the effects of amino acid sequence on the 
binding of inhibitors to specific subunits, \ve examined the 
ability of several tripeptides to inhibit substrate hydrolysis 
and to label specific /3 subunits of the proteasomc when 
converted to 1z51-labeled form. Kesults from analysis of 
inhibition of the three proteasomc substrates by the 
tripeptide \-inyl sulfones (NP-LLGVS , XI’-AAF-\3 and 
IVIP-L,-\:S) indicated that inhibition by these three com- 
pounds is nonequivalent (‘I’able 1). Neither NP-LLG-\‘S 
nor NP-AAF-V’S had a significant effect on the PGPH 
activity, although both were able to inhibit the chy- 
motrypsin activity (NP-AAF-VS is about three times 
more potent than NP-LLG-KG). 
Labeling of semi-purified proteasomes with “‘I-NIP- 
LLG-YS. ‘““I-NIP-AAF-13, and ““I-NLVS revealed dif- 
ferenccs in the relative intensity of polypeptides lab&d. 
NI,VS predominantly labclcd the p subunits X, LMP-2 
and LhlP-7 each with similar intensity. 1,abeling of Y, 
~1~1-1 and Z was also observed, but at a much lower 
intensity (Figure 9). NIP-AAF-VS showed predominant 
labeling of LT\lP-7, with a reduction in the labeling of X 
and little or no labeling of the Mecl-1 and Y subunits. lz51- 
iKIP-LLG-TS did not directly modify the LhlP-2 and 1 
subunits, but did label both Z and hlecl-1 with an intensity 
ratio that was similar to the ratio observed for ““I-NI,VS. 
The tctrapeptidc containing a glycine rcsiduc in the P4 
position (GL,3-\‘S) was found to be a weak but specific 
tag for the IdhIP-2 subunit (Figure 7). Furthermore, 
replacement of the methyl group attached to the vinyl 
sulfone moiety with a phenol resulted in an increased 
propensity of NLVS to modify the I,\IP-2 subunit 
(Figure 8). We therefore reasoned that the GL,3 core 
sequence combined with the phenolic vinyl sulfone may 
represent a potentially LhlP-Z-specific reagent. Labeling 
of total lysates from mouse EL-4 cells with 12”I-GI,,-\‘S- 
PhOH followed by immunoprecipitation and two-dimen- 
sional electrophoresis showed a specific binding of the 
I,MP-2 subunit with a minor amount of Y also modified 
(Figure 9). It could therefore be possible to generate 
subunit-specific inhibitors by modifying the P4 amino 
acid and carboxy-terminal sulfone group. 
Discussion 
The use of modified tripeptides that contain an active 
site-directed inhibitory functional group at the carboxyl 
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Figure 8 
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Chemistry & Btology ‘2%NIP-LLG-VS 
Replacement of the methyl group adjacent to the vinyl sulfone with a 
phenolic moiety results In an increase in modification of the LMP-2 
subunlt. Total lysates were labeled with ‘?NLVS and 1251-NLVS-PhOH. 
Proteasomes were isolated by lmmunoprecipitation and then separated 
by SDS-PAGE as described in the Materials and methods section. 
terminus has pro\.en to bc a valuable method for studying 
proteasomc-substrate interaaions. ‘I’hc synthesis of 3 
new series of rctrapeptidc vinyl sulfones has now uncov- 
ercd the imporunce of the P1 amino acid posiCon for 
binding and inhibition. .\lodificaGons at the carboxy-ter- 
minal portion of such compounds indicated some impor- 
tant differences in how indi\;idual proteasomal subunits 
bind substrates. In addition, direct labeling experiments 
using the inhibitors prwided a link between substrate 
binding and hydrolysis. Labeling of proreasomes with 
peptide vinyl sulfones of different sequences re\ ealed 
that binding of a substrare to individual b subunits is 
sequence dependent. 
The potcnq of a free-amino tetrapeptidc vinyl sulfonc as 
a proreasome inhibitor is remarkable compared to the 
extremely poor activiry of the corresponding free-amino 
tripcptide \.in)-I sulfone. The tripeptides capped \zith a 
bulky nitro phenol (KLVS) or benzyl (25L,-VS) moiet> 
are potent inhibitors, but- removal of the cap resulted in 
severely diminished binding and inhibition. Scveral di- 
pcptide aldchydes were described as potent inhibitors of 
the proteasome, but these inhibitors all have an amide- 
capped amino terminus (usually acetare) r1.51. The prcs- 
ence of the amide cap is likely to result in substrates or 
inhibitors that mimic :I longer peptide substrate. The 
inhibitors used in this srudy hauz the important future of 
Figure 9 
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Chemistry & Biology 
SubunIt binding IS sequence specific and sensitive to changes at both 
sides of the site of hydrolysis. Total lysates were labeled with the 
indicated i251-tagged peptide vinyl sulfones. Proteasomes were 
isolated by lmmunopreclpitations and separated In one dimension 
using non-equilibrium pH gradient electrophoresls (NEPHGE) followed 
by SDS-PAGE in a second dimension. Note the change in relative 
intensities of subunit modified upon changes In the core ammo acid 
sequence (LLL, AAF, LLG). 
conuining a free amino terminus, as cxpectcd for ;I by- 
product of a prior proteolytic processing reaction. The 
\‘ery presence of a charged free amino group within the 
active site might, in fact, be required for length detcrmi- 
narion by the proteasome. ‘l’hus, our data suggest that 
there is :I minimal length requirement for substrate 
binding and hydrolysis by the prorcasome. If so, the possi- 
bility that the proteasome digests some substraws to 
single amino acids is not very likely. 
The P+binding site is Ilnlikely to bc as specific as that for 
the Pl amino acid. Several different bulky residues, includ- 
ing a nonnatiiral amino acid conwining ;I herizophcnone 
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sidechain, are accepd in the P4 position. In addition, 
unlike the Pl position where a [)-isomer results in com- 
pletc loss of binding [4], placement of a [)-isomer at P4 
resulted in an activ-e inhibitor. albeit with reduced binding 
affinity. Thus, within the cavity of the proteasome, sec- 
ondary binding sites are likely to exist that stabilize longer 
peptidc substrates and can accommodate sidechains of 
\.arying sizes and shapes. This wo~~ld be expected for a 
protease such as the proteasome, responsible for the 
degradation of most cytosolic proteins. 
‘l‘he structural recluiremcnts for binding of the P4 amino 
acid are distinct for different acti\,e sites and different 
p subunits. The trypsin-like and chymotrypsin-like activi- 
ties of the protcasome stem to favor a bulky, aromatic or 
hydrophobic group in the P4 position, whereas the PGPH 
activity is less sensitive to changes in the P4 position. 
The dramatic increase in the extent of modification by 
‘Z”I-YL,,-VS of the hlecl-1 and Z subunits when com- 
pared to NLVS correlated with the increase in activity 
against hydrolysis of the Hoc-LRR-AhlC substrate. Fur- 
thermore, the notable decrease in potency of L,-1% rela- 
tive to NLVS, YL,3-\?3 and BpaL,-\‘S against hydrolysis 
of Sue-LLVY-AhlC correlated with a decrease in the 
extent of modification of the X and LhlP-7 subunits. as 
judged by competition experiments (Figure 7). Finally, 
the specific modification of the I,hIP-2 and Y subunits by 
GL,3-VS-PhOH and GI,,-VS correlated with increased 
activity against the Ac-YVAD-AhlC substrate. These 
findings suggest that the XIecl-1 and z subunits arc pri- 
marily responsible for cleavage after basic amino acid 
residues, LhIP-7 and X subunits predominantly for cleav- 
age after hydrophobic residues and LblP-2 and Y for 
cleavage after acidic residues. ‘l’hesc findings fit well 
with a recently reported study using ‘lC-labeled 
dichloroisocoumarin (DCI) by Orlowski and co-workers 
[16]. ‘l’hey found that the X and LhlP-2 subunits of pitu- 
itary and spleen proteasomcs are preferentially modified 
by DCI, and that this modification correlates with inhibi- 
tion of the chymotrypsin-like activity. 
Surprisingly, the observed inhibition rate constants for 
GL,-VS-PhOH are similar to those obtained for NP- 
AAF-VS, with respect to the chymotrypsin- and trypsin- 
like activities. The labeling patterns are quite different, 
however, indicating that the observed difference in inhi- 
bition of PGPH activity cannot bc accounted for solely 
by the increased modification of LMP-2 and Y by GL,3- 
\yS-PhOH. p subunits must therefore overlap, at least to 
some extent, in their substrate specificities. A single 
subunit is not likely to hydrolyze only a distinct subset of 
substrates containing a defined carboxyl terminus. This 
suggestion is supported by the finding that the HrAAP 
activity is the result of hydrolytic activity of multiple 
p subunits [ 171. 
‘l’he functional group placed adjacent to the sulfone at 
the carboxy-terminal end of the inhibitor is likely to 
mimic the Pl’ position of a protein substrate when bound 
in the acti\,e site. Our data support the notion that not all 
acti\ c sites have the same degree of specificity for the Pl’ 
position. Addition of the phenol moiety in place of the 
methyl group adjacent to the vinyl sulfone results in 
increased affinity for the LhIP-2 and Y subunits. ‘l’hcsc 
subunits ma)- thus have a greater degree of sequence 
specificity for the portion of a substrate carboxy-terminal 
to the site of hydrolysis. 
Finally, labcling of proteasomes with inhibitors of different 
sequences demonstrated that individual subunits have pro- 
nounced sequence preference. It is not surprising that b) 
changing the amino acid SCc[LJCrJCe of a tripeptide inhibitor, 
it is possible to change the relative inhibitory capacity of 
that compound. By comparing the relative changes in 
binding affinity of a compound for particular subunits, 
ho\vever, it is possible to examine how these inhibitors 
interact with individual subunits of the proteasome. Of 
interest is the ability of a NIP-A4F-\3 to bind to LRIP-7, 
\\,ith greater affinity than to X, while not modifying Mecl-1 
ar all. This is in direct contrast to NLVS, which bound both 
I,hlt’-7 and X nearly equally, and both Z and hIecl-1 to 
similar degrees. The LLG-containing tri peptidc, on the 
other hand, failed to label the L.\IP-2 or Y subunits, sug- 
gesting that these p subunits have sequence requirements 
rhat define which substrates each will hydrolyze. 
Fluorogenic substraW are often used to evaluate 
inhibitors of a protcolytic activity of an enzyme such as the 
proteasome. ‘l’hese tools, although useful, often fail to 
shed light on the underlying mechanisms by which a com- 
pound can cause inhibition. The data reported here show 
the usefulness of radiolabeled affinity reagents such as the 
vinyl sulfones, to study substrate binding. ‘l’he results 
obtained for the tetrapcptide \ inyl sulfone GL3-VS-PhOH 
also suggest that, through a combinatorial approach, it ma) 
bc possible to generate reagents that can selcctivel) 
inhibit one active site or proteolyric activity of the protea- 
some. Such reagents would bc of considerable use for 
further dcconvolution of the proteasome’s role in a wide 
range of biological processes. 
Significance 
The proteasome is a dynamic proteolytic complex that 
degrades a multitude of polypeptide substrates resulting 
in by-products of differing sequences, lengths and biologi- 
cal functions. Although the multiple proteolytic activities 
of the proteasome are usually defined according to the 
types of sidechains present immediately amino-terminal 
to the scissile bond (the PI position), our results show 
that a considerable element of specificity is contributed 
by more distal sequence elements. These observations 
raise questions as to how substrates are threaded along 
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the proteasome’s active sites. Furthermore, the use of 
‘suicide-substrate’ inhibitors has allowed a correlation 
between inhibition of hydrolytic activity and subunit 
modification. The role of individual subunits in estnb- 
lishing a specific proteolytic activity can now be 
addressed. Finally, this work shows that it is possible to 
generate subunit-selective reagents that could be used to 
further define substrate specificity and to determine the 
significance of the multiple proteoiytic activities of the 
proteasome in its many biological tasks. 
Materials and methods 
Inhibitor synthesis 
NIP-L,-!/& 1251-NIP-L,-VS, L,-VS and Z-L,-VS were synthestzed as 
described previously [4]. The synthesis of all other inhibitors are 
described below. All inhibitors were dissolved in dimethyl sulfoxide 
(DMSO) and used In blological assays at the concentrations specified. 
Stock solutions were prepared such that the concentration of DMSO 
never exceeded 1%. 
Synthesis of tetrapeptide vinyl sulfones containing the L, core 
sequence 
The tripeptide free amine L,-VS was used as a building block for the 
synthesis of the tetrapeptide vinyl sulfones containing the sequences: 
YL,-VS, (D)YL,-VS, BpaL,-VS, GL,-VS, and L,-VS The synthesis of 
these tetrapeptides were carried out by the coupling of the desired 
Boc-amtno acid to L,-VS using the same protocol for all four deriva- 
tlves. The Boc- protecting group was removed from the tetrapeptides 
by treatment with tnfluoroacetic acid (TFA). All tetrapeptides were 
characterized as the free amine salts only and are described below. 
Synthesis of Bocprotected tetrapeptide viny/ sulfones. The desired 
Boc protected amino acid (18.6 Kmol) and PyBOP (18.6 pmol) were 
dissolved In 1 ml of dichloromethane. Diisopropylethyl amine (3.3 ~1, 
18.6 vmol) was then added. The reaction was stirred for 5 min and 
L,-VS toslc acid salt (10 mg, 16.9 pmol) was added followed by dllso- 
propylethyl amine (3.0 PI, 16.9 pmol). The reactlon was stirred for 30 
min at room temperature and solvent was removed by rotary evapora- 
tion. The resulting crude reaction mixture was purlfled by flash column 
chromatography using ethyl acetate:hexane as the mobile phase. 
Synthesis of free ammo tetrapeptide viny/ sulfone frifloroacefic acid 
salts. The desired Boc-protected tetrapeptide vinyl sulfone (13.2 bmol) 
was dissolved in 1 ml of dlchloromethane. TFA (1 ml) was added and the 
reactlon stirred at room temperature for 1 h. The reaction was quenched 
by the addition of 5 ml of toluene followed by removal of the solvent by 
rotary evaporation. A second portion of toluene was then added to the 
crude solid and agaln evaporated to dryness. The pure tetrapeptide was 
obtained by trituration of the solld residue in diethyl ether. Tyroslne- 
leucine-leucine-leucine vlnyl sulfone (YL,-VS): yield (9 mg, 13 pmol, 
99%). ‘H-NMR (500 MHz, CDsOD) 6 7.05 (2H, d), 6.80 (1 H, dd), 6.70 
(2H, d), 6.64 (1 H, t), 4.7 (1 H, m), 4.45 (1 H, m), 4.20 (1 H, dd), 3.25 (1 H, 
m), 2.95 (3H, s), 2.95 (2H, ddd), 1.50-1.78 (9H, M), 0.95 (18H, m). FAB 
mass spectrum: [M+H] calc’d for C,,H,,N,O,S: 581.7; found: 581.4. 
(D)-tyrosine-leucine-leuclne-leucine vinyl sulfone ((D)YL,-VS): Yield 
(70%).‘H-NMR (500 MHz, CD,OD) 6 7.05 (2H, d), 6.80 (1 H, dd), 6.70 
(2H, d), 6.64 (IH, t), 4.65 (IH, m), 4.45 (IH, m), 4.20 (IH, dd), 3.25 
(1 H, m), 2.95 (3H, s), 2.95 (2H, ddd), 1.50-l .78 (9H, M), 0.95 (18H, m). 
FAB mass spectrum: [M+Hl calc’d for C,,H,,N,O,S: 581.7; found: 
581.4. Glyclne-leucine-leucme-leucine vlnyl sulfone (GL,-VS): yield 
(74%). 1 H-NMR (500 MHz, CD,OD) d 6.78 (1 H, dd), 6.58 (1 H, d), 4.65 
(lH, m), 4.43 (IH, dd) 4.39 (IH, m), 3.71 (2H, s), 2.98 (3H, s), 1.43- 
1.71 (9H, m), 0.94 (18H, m). FAB mass spectrum: [M+Hl calc’d for 
C,2H,2N,0,S: 475.6; found: 475.3. Leucine-leucine-leuclne-leucine 
vlnyl sulfone (L4-VS): yield (84%). 1 H-NMR (500 MHz, CD,OD) d 6.78 
(IH, dd), 6.58 (IH, d), 4.65 (IH, m), 4.48 (IH, dd), 4.39 (IH, m), 2.97 
(3H, s), 1.43-l .74 (12H, m), 0.91-l .17 (24H, m). FAB mass spectrum: 
[M+H] calc’d for CzBH,,N,O,S: 531.7; found 531 .l. Benzoylphenylala- 
nine-leuclne-leucine-leucine vinyl sulfone (BpaL,-VS) yield (Boc-Bpa-L,- 
VS 92%, 96%).‘H-NMR (500 MHz, CD,OD) 6 7.78 (4H, dd), 7.65 (1 H, 
t), 7.55 (2H, t), 7.45 (2H, d), 6.79 (IH, dd), 6.59 (lH, d), 4.65 (IH, m), 
4.45 (lH, dt), 4.18 (1H. t), 3.18 (lH, m), 2.98 (3H, s), 1.30-1.75 (SH, m), 
0.95 (18H, m). FAB mass spectrum: [M+Hl calc’d for C,,H,,N,O,S: 
669.8; found: 669.5 
Synthesis of NP-AAF 
The NP-AAF-VS peptide vlnyl sulfone was synthesized essentially as 
described for the synthesis of NLVS 141. The synthetic details are 
described below. 
Synthesis of i3ocpheny/a/anine viny/ sulfone (Boc-Phe-VSJ. Boc- 
phenylalanlne vinyl sulfone was synthesized exactly as described for the 
synthesis of Boc-leuclne vinyl sulfone [4], except that Boc-phenylalanlne 
was used In place of Boc-leucine. The NMR data and typlcal yields 
obtalned for each intermediate are listed. Boc-Phe-dimethyl hydroxyl 
amide: yield (970/o), ‘H-NMR (300 MHz, CDCI,) 6 7.18-7.38 (5H, m), 
5.19 (lH, d), 4.98 (lH, m), 3.69 (3H, s), 3.20 (3H, s), 3.0 (2H, ddd), 
1.40 (3H, s). Boc-Phenylalaninal: yield (73%), ‘H-NMR (300 MHz, 
CDCI,) 6 9.65 (lH, s), 7.18-7.38 (5H, m), 5.05 (IH, d), 4.44 (lH, m), 
3.15 (2H, d), 1.45 (9H, s). Boc-Phe-VS: yield (73%) ‘H-NMR (300 MHz, 
CDCI,) 6 7.35 (3H, q), 7.19 (2H, d), 6.90 (1 H, dd), 6.39 (lH, dd), 4.67 
(1 H, m), 4.58 (1 H, d), 2.95 (2H, d), 2.93 (3H, s), 1.43 (9H. s). 
Synthesis of phenylalanine-my/ sulfone fox acid salt (Phe-VS). 
Phenylalanine-vinyl sulfone was synthesized from Boc-Phe-VS by 
removal of the Boc-protecting group using toslc acid as described for 
Boc-leucine-vinyl sulfone [4]. Phe-VS tosic acid salt ‘H-NMR (300 
MHz, CD,OD) 6 7.74 (2H, d), 7.35 (3H, q), 7.25 (4H, d), 6.74 (2H, m), 
4.29 (1 H, q), 2.99-3.23 (2H, ddd), 2.89 (3H, s), 2.39 (3H, s). 
Syntheses of Boc-alamne-alanme methyl ester (Boc-AA-OMe). To a 
flask was added Boc-alanine (2.0 g, 10.5 mmol), dicyclohexylcarbodi- 
lmlde (DCC; 2.4 g, 11.6 mmol), and HOBt (1.57 g, 11.6 mmol) in 
25 ml dimethyl formamide (DMF). The reaction was stlrred for 30 min at 
room temperature. A white precipitate formed upon standing. Alanine- 
methyl ester hydrochloride salt (2.2 g, 15.8 mmol) was then added fol- 
lowed by dllsopropylethyl amlne (DIEA; 2.8 ml, 15.8 mmol). The 
reaction was stirred overnlght at room temperature. Next, the crude 
reaction mix was filtered to remove precipitated solids and evaporated 
to a mlnimal volume by rotary evaporation. The resulting crude solution 
was diluted with 250 ml ethyl acetate and extracted with 3 x 75 ml por- 
tions of 0.1 N HCI and 3 x 75 ml portions of saturated sodium bicar- 
bonate. The remalmng organic phase was dried over MgSO, and dned 
to a solid by rotary evaporation. The pure di-peptide methyl ester was 
isolated by re-crystallization from ethyl acetatelhexane. yield (2.1 g, 
7.6 mmol. 72%). Boc-AA-OMe ‘H-NMR (300 MHz, CDCI,) 6 6.64 (1 H, 
d), 5.01 (IH, d), 4.54 (IH, p), 4.15 (lH, q) 3.73 (3H, s), 1.42 (SH, s), 
1.40 (3H, d). 1.38 (3H, d). 
Synthesis of Boc-alanine-alanine (Boc-AA-OH). The methyl ester of 
Boc-AA was converted to the correspondtng acid by hydrolysis using 
sodium carbonate and methanol. This compound was used In subse- 
quent steps without further purification. 
Synfhesjs of Boc-alanme-alanine-phenylalanine vmyl sulfone (Boc- 
AAF-VS). Boc-AAF-VS was synthesized by reaction of Boc-AA-OH 
with phenylalanine-vInyI sulfone tosic acid salt using the protocol 
described for the synthesis of Boc-protected tetrapeptide vinyl sul- 
fones described above using PyBOP as the coupling agent. The 
product was purified by flash column chromatography using ethyl 
acetate/hexane (4:l v:v) as the moblle phase. Yield (57%). 
Boc-AAF-VS ‘H-NMR (300MHz, CDCI,) 6 7.25-7.38 (4H, m), 7.20 
(2H, d), 7.12 (IH, d), 6.88 (IH, dd), 6.60 (IH, d), 6.56 (IH, d), 4.98 
(1 H, m), 4.37 (1 H, t), 4.05 (1 H, q), 2.95 (2H, dd), 2.90 (3H, s), 1.48 
(9H, s), 1.36 (3H, d), 1.34 (3H, d). 
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Synthesis of alanine-alaninephenylalanine vinyl sulfone tosic acid salt 
(AAF-L/S). The Boc protecting group was removed from Boc-AAF-VS 
using the protocol described for removal of Boc from Boc-Ls-VS [l]. 
Yield (95%). AAF-VS IH-NMR (300 MHz, CDaOD) 6 7.74 (2H, d), 
7.20-7.38 (7H, m), 6.85 (1 H, dd), 6.56 (1 H, d), 4.82 (1 H, q), 4.32 (1 H, 
q), 3.95 (1 H, q), 2.99 (2H, dd), 2.90 (3H, s), 2.39 (3H, s), 1.50 (3H, d), 
1.32 (3H, d). FAB mass spectrum: ]M+Hl calc’d for C,,H,,N,O,S: 
368.4; found: 368.3 
Synthesis of /VP-AAF-VS. 4-hydroxy-3-nitrophenyl acetic acid was 
coupled to the free amino AAF-VS using PyBOP as described above 
for the Boc-tetrapeptide vinyl sulfones. Yield (78%). NP-AAF-VS 1 H- 
NMR (300 MHz, CDBCN) F 10.4 (lH, s), 8.08 (lH, s), 7.60 (lH, d), 
6.95-7.29 (SH, m), 6.72 (1 H, dd), 6.53 (1 H. d), 4.69 (1 H, t), 4.08 (2H, 
m), 2.85 (3H, s), 2.84 (1 H, m), 2.65 (lH, m), 2.15 (2H, d), 1.35 (3H, 
d), 1 .I 2 (3H, d). FAB mass spectrum: [M+H] calc’d for C,,H,,N,OsS: 
547.5; found: 547.1. 
Synthesis of LLG containing vinyl sulfones 
Vinyl sulfones containing glycine at position Pl were synthesized as 
described for the synthesis of the tri-leucine vinyl sulfones except that 
the Boc-glycinal intermediate was prepared by the oxidation of Boc-3- 
ammo-1,2-propane dial. The resulting aldehyde was converted to the 
corresponding vinyl sulfone as described for the synthesis of Boc- 
leucine vinyl sulfone. 
Synthesis of Boc-3-amino-1,2-propane dial 3-amino-1,2-propane diol 
(5.0 g, 55 mol) was dissolved in 20 ml of 1,4-dioxane and 10 ml of 3M 
NaOH. Di-tert-butoxy carbonyl ((Boc),O; 12 g, 55 mmol) was added 
and the reaction stirred for 4.5 h until the evolution of gas ceased. The 
solvent was removed by rotary evaporation and the resulting crude 
whrte solid dissolved in ethyl acetate. The ethyl acetate solution was 
washed with 3 x 50 ml portions of 5% potassium hydrogen sulfate 
(KHSO,). The aqueous layers were combined and back-extracted with 
ethyl acetate. All organic layers were combined, dried over MgSO,, 
and concentrated to an oil by rotary evaporation. The crude oil was 
used in subsequent steps without further purification. 
Synthesis of Boc-glycinal (Boc-G/y-H). Boc-3-amino-1,2-propane diol 
(3.8 g, -20 mmol) was dissolved as a crude oil in 30 ml of ethanol. 
Sodium periodate (NalO,; 12.8 g, 60 mmol) was added as a solution in 
90 ml of 0.01 M phosphate buffer (pH 7). The reaction was then stirred 
for 1.5 h. The reaction mix was washed with 3 x 50 ml portions of chlo- 
roform with the addition of 50 ml of saturate sodium chloride (to sepa- 
rate organic and aqueous phases). The organic phases were 
combined, dried over MgSO, , and evaporated to dryness. The crude 
Boc-glycinal was used in subsequent steps without further purification. 
Synthesis of Boc-glycine vinyl sulfone, cis and trans isomers (Boc- 
G-cl/S and Boc-G-tVS). The cis and trans isomers of Boc-glycine 
vinyl sulfone were synthesized from the crude Boc-glycinal as 
described for the synthesis of Boc-leucine vrnyl sulfone from Boc- 
leucinal [4]. This reaction resulted in two compounds that were sepa- 
rable by flash chromatography using hexane: ethyl acetate (2:l) as 
the mobile phase. Mass spectrum obtained for the two tripeptides 
isolated were identical (NP-LLG-tVS and NP-LLGcVS; see below) 
indicating that they were likely to be isomers. As enantiomers are not 
likely to be resolved by column chromatography, we concluded that 
the lack of a sidechain on glycine allowed for the formation of both 
the cis and trans isomers of the newly formed double bond. NMR 
data (see below) confirmed this hypothesis. The two compounds had 
nearly identical spectra with the largest difference observed for the 
vinyl resonances. The alpha carbon was also found to be slightly dif- 
ferent for the two isomers. These data were consistent with cisltrans 
geometric isomers. Finally the cis and trans isomers were assigned 
usrng Z-factor calculations [18] to predict the chemical shift of the 
vinyl protons for the cis and trans isomers. The greatest difference in 
shifts between the two vinyl resonances was found for the cis isomer 
and was reflected in the NMR obtained for the slightly less polar 
compound isolated. Yield (2:l trans:cis, 43 % overall yield). Boc- 
glycine vinyl sulfone cis isomer ‘H-NMR (300 MHz, CDCI,) 6 6.45 
(1 H, dd), 6.32 (1 H, d), 4.98 (1 H, m), 4.28 (2H, t), 3.04 (3H, s), 1.45 
(9H, s). Boc-glycine vinyl sulfone trans isomer ‘H-NMR (300 MHz, 
CDCI,) 6 6.94 (1 H, dt), 6.52 (1 H, dt), 4.78 (lH, m), 4.00 (2H, t), 
2.96 (3H, s), 1.45 (9H, s). 
Synthesis of g/y&e-vinyl sulfone tosic acid salt cis and trans isomers 
(G-cVS, G-MS). The Boc protecting group was removed from the 
glycine vrnyl sulfones as described for the removal of Boc from Boc- 
leucine vinyl sulfone described above. Yield (97%). Glycine vinyl 
sulfone cls isomer ‘H-NMR (300 MHz, CD,OD) 6 7.72 (2H, d), 7.24 
(2H, d), 6.78 (lH, dt), 6.43 (lH, dt), 4.21 (2H, d), 3.08 (3H, s), 2.38 
(3H, s). Glycine vinyl sulfone trans isomer 1 H-NMR (300 MHz, CDsOD) 
6 7.72 (2H, d), 7.24 (2H, d), 6.95 (lH, d), 6.87 (lH, dt), 3.84 (2H, d), 
3.02 (3H, s), 2.38 (3H, s). 
Synthesis of Boc-leucinyl-leucinykglycine vinyl sulfone cis and trans 
isomers (Boc-LLG-cl/S, Boc-LLG-tVS). BOG-LLG-VS cls and trans 
isomers were synthesized from the tosic acid salts of cis and trans 
glycine vrnyl sulfone as described for the syntheses of Boc-Ls-VS The 
compounds were purified by flash column chromatography using ethyl 
acetate as the mobile phase. Yield (95%). Boc-LLG-cVS IH-NMR 
(300 MHz, CDCI,) 6 7.52 (lH, m), 6.88 (lH, dq), 6.63 (lH, t), 6.54 
(1 H, d), 5.09 (1 H, dd), 4.44 (1 H, mf, 3.94-4.09 (2H, m), 2.93 (3H, s), 
1.40-t .82 (6H, m), 1.42 (9H, d), 0.95 (12H, m). Boc-LLGtVS ‘H-NMR 
(300 MHz, CDCI,) 6 7.52 (1 H, m), 6.56 (1 H, d), 6.30 (2H, m), 5.05 
(1H. dd), 4.47 (lH, m), 4.34 (lH, t), 4.03 (lH, m), 3.06 (3H, s), 1.40. 
1.82 (6H, m), 1.42 (9H, d), 0.95 (12H, m). 
Synthesis of leucinyl-leucinyl-glycine vinyl sulfone tosic aud salt CIS 
and trans isomers (LLG-cVS, LLG-tVS,J. The Boc protecting group 
was removed as described for the removal of Boc from Boc-leucine- 
vinyl sulfone described above. Yield (52% ) 
Synthesis of 4-hydroxy-3-nitrophenyl acetyl-leucine-leucine-gfycine viny/ 
sulfone cis and trans isomers (/VP-LLG-cVS, NP-LLG-tVSJ. The hapten 
4-hydroxy-3-nitrophenyl acetic acid was added to LLG-VS cis and trans 
isomers as described for the synthesis of NP-AAF-VS above. The cis and 
trans products were purified by flash column chromatography using ethyl 
acetate as the mobrle phase. NP-LLG-cVS ‘H-NMR (300 MHz, DMSO- 
d,) 6 8.29 (1 H, d), 8.26 (1 H, t), 7.96 (1 H, d), 7.80 (1 H, s), 7.44 (1 H, d), 
7.05 (IH, d), 6.53 (lH, dt), 6.18 (lH, dt), 4.13-4.36 (4H, m), 3.47 (2H, 
s), 3.10 (3H, s), 1.48-I .62 (6H, m), 0.75-0.90 (12H, m). FAB mass spec- 
trum: [M+H] calc’d for C,,H,,N,O,S: 541.6; found: 541.3. NP-LLG-tVS 
‘H-NMR (300 MHz, DMSO-d,) 6 8.29 (1 H, d), 8.22 (1 H, t), 7.79 (1 H, s), 
7.42 (1 H, d), 7.05 (1 H, d),6.70 (1 H, dt), 6.64 (1 H, d), 4.28 (2H, m), 3.94 
(1 H, t), 3.89 (1 H, t), 3.46 (2H, d), 2.98 (3H, s), 1.48-l .62 (6H, m), 0.75- 
0.90 (12H, m), FAB mass spectrum: ]M+Hl calc’d for C,,H,,N,O,S: 
541.6; found: 541.3. 
Synthesis of phenolic vinyl sulfones 
The phenolic vinyl sulfones were synthesized using the same protocol 
as described for the methyl vinyl sulfones except the phenolic version 
of the corresponding methyl phosponate sulfone was used. 
Syntheses of 4-Hydroxy-thiophenyl-methyl-diethylphosponate 
ffEtOl,P(O~CH,S-fh-OHi. To a dried flask flushed with argon was 
added 4-hydroxy-thiophenol (90% stock, 4.44 g, 31.7 mmol) in 20ml 
of diethyl ether. Sodium hydride (1.27 g, 31.7 mmol) was slowly 
added and the reaction stirred at room temperature for 30 min. A solrd 
mass formed upon standing. Diethyl iodomethyl phosphonate (8.11 g, 
29.17 mmol) was added as a solution in 15 ml of diethyl ether. The 
reaction was then stirred at room temperature for three hours. The 
reaction was quenched with 60 ml of 0.5 M citrate buffer (pH 4.0) and 
the resulting aqueous phase was extracted with 3 x 40 ml volumes of 
diethyl ether. The combined organic layers were dried over MgSO, 
and concentrated to an oil. The crude oil was oxidized as described 
below without further purification. 
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Synthesis of 4-Hydroxy-thiophenyl-methyl-diethylphosponate sulfone 
((EtO),PfO)CH,S(Oj,-Ph-OH). Th e crude oil of 3-hydroxy-thiophenyl- 
methyl-diethylphosponate was dissolved in 30 ml of 1,4-dioxane and 
chilled on ice. Peracetic acid (30 ml, 32% solution, 145 mmol) was 
slowly added while stirring the reaction mixture. The reaction was main- 
tained on ice for 20 minutes and then warmed to room temperature for 
4 h. Crushed platinum on carbon (2.8 g) was added and the reaction 
stirred overnight at room temperature. Potassium iodide was used to 
insure that no peracetic acid remained. The platinum carbon solids were 
removed by filtration and the remaining solution diluted with 250ml of 
saturated sodium bicarbonate. The aqueous phase was extracted with 
3 x 100 ml portions of ethyl acetate. The combined organic layers were 
dried over MgSO, and dried to a crude solid by rotary evaporation. The 
pure product was obtained by recrystallization from hexane/ethyl acetate 
(1 :2). Yield (7.1 g, 23.4 mmol, 80%). 4-hydroxy-thiophenyl-methyl 
diethylphosponate sulfone ‘H-NMR (300 MHz, CDCI,) 6 9.25 (1 H, s), 
7.80 (2H, d), 6.75 (2H, d), 4.22 (4H, p), 3.81 (2H, d), 1.36 (6H, t). 
Synthesis of leucine-leucine-leucine viny/ sulfone phenol tos/c acid 
salt (L;VS-PhOH). L,-VS was synthesized as described previously [4] 
except that for the conversion of Boc-leucinal to Boc-leucine vinyl 
sulfone 4-hydroxy-thiophenyl-methyl diethylphosponate sulfone was 
used instead of methyl-thiomethyl diethylphosponate sulfone. The 
yields obtained in a typical reaction were similar to those reported for 
the methyl derivative. L,-VS-PhOH ‘H-NMR (300 MHz, CD,OD) 6 7.68 
(2H, d), 6.95 (2H. d), 6.78 (lH, dd), 6.45 (IH, d), 4.61 (lH, m), 4.42 
(1 H, t), 3.85 (1 H, t), 1.40-I .78 (SH, m), 0.82-l .02 (18H, m). FAB mass 
spectrum: [M+H] calc’d for C,,H,,N,O,S: 496.6; found: 496.3 
Synthesis of 4-hydroxy-5iodo-3-nitrophenyl acetyl-leucine-leucine- 
leucine viny/ sulfone phenol and glycne-leucine-leucine-leucine viny/ 
sulfone phenol (NLVS-PhOH, GL;KS-PhOH). NLVS-PhOH was syn- 
thesized by addition of 4-hydroxy-5iodo-3-nitrophenyl acetic acid to L,- 
VS-PhOH as described above. GL,-VS-PhOH was synthesized by 
coupling of Boc-glycine to L,-VS-PhOH with PyBop followed by depro- 
tection of the Boc group using trifluoroacetic acid as described above. 
Similar yields were obtained. NLVS-PhOH ‘H-NMR (300 MHz, DMSO- 
D6) F 8.30 (IH, d), 8.06 (2H, d), 8.00 (lH, s), 7.89 (IH, s), 7.61 (2H, 
d), 6.94 (2H, d), 6.60 (lH, dd), 6.50 (lH, d), 4.52 (lH, m), 4.22 (2H, 
m). 1.28-1.65 (9H, m), 0.73-0.98 (18H, m). FAB mass spectrum: 
[M+HI calc’d for C,,H,,N,O,SI: 801.7; found: 801.4. GL,-VS-PhOH 
1 H-NMR (500 MHz, CD,OD) 6 7.67 (2H, d), 6.92 (2H, d), 6.75 (1 H, 
dd). 6.46 (1 H, d), 4.61 (1 H. m), 4.41 (1 H, dd), 4.34 (1 H, m). 3.69 (2H, 
s), 1.41-l .69 (9H, m), 0.86-1.00 (18H, m). FAB mass spectrum: 
[M+Hl calc’d for C27H44N406S: 553.7; found: 553.3. 
Cells and cell culture 
The mouse lymphoblastoid cell line EL-4 was maintained in Dulbecco’s 
Modified Eagle’s Medium supplemented with 10% fetal calf serum. The 
human EBV-transformed cell line HOM-2 was mamtained as described 
previously 1191. 
Antibodies 
The poly-clonal rabbit sera against whole proteasome, LMP-7, LMP-2, 
Mecl-I, X, Y and Z were kind gifts of Migel Cruez and John Monaco 
(University of Cincinnati, Cincinnati, OH). The sera were prepared using 
20s proteasomes and purified, recombinant /3 subunits as immunogens. 
Nuorogenic substrate hydrolysis assay 
Hydrolysis of the fluorogenic substrates: Sue-LLVY-AMC (chymo- 
trypsin-like substrate), Boc-LRR-AMC (trypsin-like substrate), and Ac- 
YVAD-AMC (PGPH substrate) was measured. In a typical assay 0.4 pg 
of purified rabbit muscle 20s proteasomes (gift of Fred Goldberg, 
Harvard Medical School) was diluted to a final volume of 500 ~1 in 
buffer A (20 mM HEPES pH 8.0, 0.5 mM EDTA and 0.01% SDS). Flu- 
erogenic substrates were added to a final concentration of 5 PM and 
progress curves measured by monitoring methyl coumaric acid (MCA) 
fluorescence (em = 460 nm, ex = 380) at 37°C. Inhibitors were added 
in the concentration ranges indicated after hydrolysis reached steady 
state. The reaction was allowed to proceed for an additional 45 min. at 
37°C. Fluorescence data were collected as a function of time and 
processed using the Sigma Plot scientific graphing program. kobs 
values were obtained by a non-linear least squares fit of the data to the 
equation for time-dependent or slow-binding inhibltion [20]: 
Fluorescence = v,t + I(v,-v,)/k,,,l [l -exp(-k&)1 (1) 
Where v, is the initial velocity that decays over time to a flnal velocity 
v, with a rate constant. kobs. k,,,/[l] values are reported as an average 
of three independent experiments obtained with different inhibitor 
concentrations. 
Preparation of lysates from EL-4 cells 
Cells were lysed using a bead smashing technique. Briefly, cells were 
washed three times with cold PBS and then pelleted. A volume of glass 
beads (< 106 microns, acid washed; Sigma Chem. Co., St. LOUIS, MO) 
equivalent to the volume of the pellet were added followed by a similar 
volume of homogenization buffer (50 mM Tris pH 7.4, 1 mM DTT, 5 mM 
MgCI,, 2 mM ATP, 250 mM sucrose). Cells were vortexed at high 
speed for 1 min. The beads and broken cell debris were removed by 
centrifugation at 10,000 g for 5 min. The resultant homogenate was 
centrifuged at 10,000 g for 20 min to remove unbroken cells and nuclei. 
Protein concentration was determined using the BCA protocol 
described by the manufacturer (Pierce Chem. Co., Rockford, IL). 
Labeling of proteasomes with peptide vinyl sulfones 
Radioactive concentrations of the stock solutions of 1251-labeled 
inhibitors were determined so that equivalent amounts of radioactivity 
were used for all labeling experiments. It should be noted, however, that 
not all inhibitors may not have been modified to the same extent during 
iodinatlon [41. It is thus difficult to determine the amount of unlabeled 
Inhibitor present in a given labeling stock. As any unlabeled Inhibitor may 
serve to compete for the proteasome active site and thus, decrease 
labeling, these reagents cannot be used as quantitative measures of 
inhibitory activity. Relative inhibition of radiolabeling of specific e sub- 
units by cold competition can be assessed reliably in this fashion. In 
labeling experiments, labeled inhibitors were added to a final concentra- 
tion of 1.8x 1 O4 Bq/ml. Samples were labeled for 2 h at 37’C unless 
noted otherwise. Samples were quenched by dilution of 4 x SDS 
sample buffer to 1 x (for one-dimensional SDS-PAGE) or by dissolving 
urea to a final concentration of 9.5 M (for two-dimenslonal SDS-PAGE). 
Competition experiments 
GL,-VS, YL,-VS, Bpa-L,-VS, NLVS, and L,-VS (0, 1, 5 and 10 FM) 
were added simultaneously with 1251-YL,-VS (1.8 x 1 O4 Bq/ml) to EL-4 
lysates prepared as described above (100 pg total protem in 100 ~1 
homogenization buffer; see above). Samples were incubated for 2 h at 
37X, the labeling reaction quenched by the addition of 30 pl 4 x SDS- 
sample buffer and heating to 95°C for 10 min. Samples were sepa- 
rated by 12.5% SDS-PAGE and then subjected to autoradiography. 
Labeled polypeptide bands were quantitated by densitometry using an 
Alphalmager 2000 (Alpha lnnotech Corporation). 
Gel electrophoresis 
One-dimenslonal SDS-PAGE, two-dimensional, non-equilibrium pH gra- 
dient SDS-PAGE (NEPHGE) [21], and fluorography [22] were performed 
as described. 
Immune-precipitation 
All tmmuno-precipitations were performed as described previously [23]. 
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